Skip to main content
. 2022 Jan 26;18(1):e1009820. doi: 10.1371/journal.pcbi.1009820

Fig 5. Metabolism assays using recombinant CYP2C9 supersomes for the identification of CYP2C9-produced metabolites.

Fig 5

The suggested metabolite structures for abemaciclib, tarafenacin, cloperidone and vatalanib are shown.